Cage Pharma
Manufacturing · Morocco · 11-50 Employees
View Company Info for Free
Overview
Headquarters
MoroccoPhone Number
(917) 733-1542Website
www.cagephar.maRevenue
<$5 MillionIndustry
About Cage Pharma
Is Cage Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cage Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cage Pharma
Cage Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cage Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cage Pharma is spiking on competitors!
Click to see if Cage Pharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Cage Pharma has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cage Pharma launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Cage Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cage Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cage Pharma.
Cage Pharma Tech Stack
A closer look at the technologies used by Cage Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cage Pharma
Cage Pharma, Inc. is a preclinical bio-pharmaceutical company focused on developing innovative therapies for cancer treatment. The company is currently pursuing a Phase 1 clinical study for its lead compound, CP-102, which targets tumor metabolism by specifically inhibiting tumor glycolysis. Their primary clients include healthcare providers and re... Read More